Compare ACFN & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACFN | MYO |
|---|---|---|
| Founded | 1986 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.2M | 39.2M |
| IPO Year | N/A | 2017 |
| Metric | ACFN | MYO |
|---|---|---|
| Price | $15.15 | $0.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 65.9K | ★ 775.1K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 473.47 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | $12,630,000.00 | ★ $41,643,203.00 |
| Revenue This Year | N/A | $24.07 |
| Revenue Next Year | N/A | $17.48 |
| P/E Ratio | $5.72 | ★ N/A |
| Revenue Growth | 30.11 | ★ 65.00 |
| 52 Week Low | $12.42 | $0.71 |
| 52 Week High | $33.00 | $7.17 |
| Indicator | ACFN | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 47.62 | 52.38 |
| Support Level | $14.85 | $0.91 |
| Resistance Level | $16.09 | $1.05 |
| Average True Range (ATR) | 1.45 | 0.08 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 48.99 | 41.95 |
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).